A new era of early cancer detection with blood test may change cancer screening paradigms

New tests can detect common cancer signal across over 50 types of cancer from tumour DNA in blood

14-Sep-2022 - Cancer doctors, care providers and payers need to get ready for a major shift in early cancer detection that will affect almost every stage of cancer diagnosis and treatment. New data supporting the accuracy of multi-cancer early detection (MCED) blood testing (1), presented at the ESMO Congress ...

Routine blood test predicts how long cancer patients will survive

20-Dec-2016 - A routine blood test can predict how long cancer patients in palliative care will survive, researchers report at the ESMO Asia 2016 Congress in Singapore. "Cancer patients in palliative care want honest and accurate prognostic information but this information needs to be shared sensitively and in ...

ESMO President 2018-2019 announced

24-Jun-2015 - The European Society for Medical Oncology (ESMO) announced that the President for the 2018-2019 period will be Josep Tabernero, Head of the Medical Oncology Department at the Vall d'Hebron University Hospital, and Director of the Vall d'Hebron Institute of Oncology (VHIO) in Barcelona, ...

Evidence grows that melanoma drugs benefit some lung cancer patients

Many patients with BRAF-mutant cancers benefit from treatment with BRAF inhibitors, European researchers report at ELCC

22-Apr-2015 - A subset of lung cancer patients can derive important clinical benefits from drugs that are more commonly used to treat melanoma, the authors of a new academic clinical trial in Europe have reported at the European Lung Cancer Conference (ELCC) in Geneva, Switzerland.Dr. Oliver Gautschi, a ...

DNA blood test detects lung cancer mutations

Circulating tumour DNA in blood a valid option for EGFR testing in patients who do not have accessible tumour tissue, study shows

21-Apr-2015 - Cancer DNA circulating in the bloodstream of lung cancer patients can provide doctors with vital mutation information that can help optimise treatment when tumour tissue is not available, an international group of researchers has reported at the European Lung Cancer Conference (ELCC) in Geneva, ...

Smokers underestimate risks of a few cigarettes

Survey shows that many live in ‘denial’ of the real risks of smoking even a small number of cigarettes a day

20-Apr-2015 - Many people still dangerously underestimate the health risks associated with smoking even a few cigarettes a day, despite decades of public health campaigning, French researchers have reported at the European Lung Cancer Conference (ELCC) in Geneva, Switzerland. The results demonstrate powerfully ...

Immunotherapy set to revolutionise cancer treatment

24-Nov-2014 - Immunotherapy is set to revolutionise the treatment of cancer, according to ESMO President Professor Rolf A. Stahel. His comments come as the ESMO Symposium on Immuno-Oncology 2014 is about to open in Geneva, Switzerland.“We expect that the new possibilities of immunotherapy will substantially ...

ESMO supports World Cancer Day cautioning that the era of personalised cancer medicine is not here yet

05-Feb-2013 - The European Society for Medical Oncology (ESMO) supports the 2013 World Cancer Day by trying to dispel the myth that personalised medicine is already a reality for all cancer types and all cancer patients, highlighting the need for more in-depth education and wider collaborations between ...

Targeted drug shows clinical benefits in melanoma brain metastases

22-May-2012 - A new cancer drug, dabrafenib, may add vital months to the lives of patients whose melanoma has spread to their brains, an early study has shown. The results represent a promising step forward in the treatment of this potentially deadly cancer, commented Prof Wolfgang Wick, member of the ESMO ...

Oncologists recognized by ESMO for outstanding contributions to cancer research and treatment

19-Sep-2011 - The European Society for Medical Oncology (ESMO) has honored three of Europe’s leading medical oncologists with prestigious awards recognizing their achievements in clinical care and research.“The eminent oncologists we are celebrating with these awards have each made enormous contributions to ...